Previous close | 1,429.85 |
Open | 1,449.70 |
Bid | 1,480.90 x 0 |
Ask | 1,480.85 x 0 |
Day's range | 1,432.00 - 1,483.85 |
52-week range | 977.30 - 1,638.85 |
Volume | |
Avg. volume | 2,890,988 |
Market cap | 3.553T |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 37.13 |
EPS (TTM) | 39.89 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | 12.50 (0.86%) |
Ex-dividend date | 09 Feb 2024 |
1y target est | 829.22 |
In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want to skip our detailed analysis of the pharmaceutical drugs market, you can go directly to 5 Most Valuable Drug Companies in 2024. The Global Pharmaceutical Drugs Market According to a report by The Business Research […]
The Indian drugmaker, which currently owns about 78.5% stake in Taro, had offered to buy its remaining stake for $38 per share in May. Upon completion of the merger, which is expected to close in the first half of the year, Taro would become a privately held company and will be delisted from the New York Stock Exchange, the companies said. The U.S. government had in November dismissed charges against a former Taro executive who was accused of conspiring to fix generic drug prices between 2013 and 2015.
In this article, we will look into the top 20 most valuable Indian companies. If you want to skip our detailed analysis, you can go directly to the Top 5 Most Valuable Indian Companies. An Outlook of the Indian Economy According to Deloitte’s Indian Economic Outlook 2023, The Indian economy is poised to emerge as […]